Cambrex announced that their stability storage business, First Quarter Scientific, has opened a new 20,000 sq ft cGMP facility in Belgium, expanding its capacity for environmentally-controlled stability storage services to the pharmaceutical, medical device and life sciences industries across Europe. Strategically located in the Liège region and approximately 90 kilometers from Brussels, the new state-of-the-art temperature-controlled and monitored storage facility provides 35,000 temperature-controlled storage spaces for all key ICH climatic zones, including long-term, intermediate, and accelerated stability trials including 2 – 8°C, 25°C /60%RH and 40°C /75%RH. From this new location, First Quarter Scientific will serve pharmaceutical companies across Europe under the leadership of the new Belgium General Manager, Cécile Jacoby.

This expansion into Belgium complements First Quarter Scientific's existing footprint in Waterford, Ireland, and is consistent with Cambrex's strategy to expand its portfolio of specialized solutions for pharmaceutical development and manufacturing across North America and Europe.